RT Journal Article
SR Electronic
T1 Combined Therapy against Recurrent Hemangiopericytoma: A Case Report
JF Cancer Biology and Medicine
JO Cancer Biol Med
FD China Anti-Cancer Association
SP 141
OP 143
DO 10.3969/j.issn.2095-3941.2012.02.012
VO 9
IS 2
A1 Li, Xiao-dong
A1 Jiang, Jing-ting
A1 Wu, Chang-ping
YR 2012
UL http://www.cancerbiomed.org/content/9/2/141.abstract
AB A patient with a seven-year history of recurrent metastatic hemangiopericytoma (HPC) was admitted. During his treatment, he received surgical resection, radiotherapy, radiofrequency hyperthermia and chemotherapy using combined doxorubicin, dacarbazin, vincristine, ginsenoside Rg3, and recombinant human endostatin. This synergistic method provides an encouraging model for treating HPC.